Skip to main content
. 2023 Nov 15;13(11):5218–5235.

Table 3.

Percentage of CD8+CD3+/CD3+ in different position

Group Peripheral Blood Tumor
Normal 25.6±1.2 -
Control 31.5±1.6‡‡ 11.6±0.8
α-PD-L1 38.2±1.4** 20.2±1.4**
Mock 30.9±1.4 11.4±0.9
siTP53TG1 28.4±1.3 9.7±0.7
siTP53TG1+α-PD-L1 37.0±1.5ΔΔ 18.8±1.1ΔΔ
‡‡

P<0.01 vs. normal;

**

P<0.01 vs. control;

ΔΔ

P<0.01 vs. siTP53TG1.